AGT and chronic kidney disease: Our main objectives were: (1) to develop methods for urine-based quantification of kidney Ang II activity proteins; (2) to optimize peptide quantification in urine samples, and (3) to demonstrate the potential relevance of Ang II-regulated proteins in patients with ADPKD and CKD.